quinidine has been researched along with Ataxia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruno, C; Budriesi, R; Carbonara, R; Carocci, A; Catalano, A; Colabufo, NA; Conte Camerino, D; De Palma, A; Desaphy, JF; Di Mola, A; Franchini, C; Ghelardini, C; Lentini, G; Perrone, MG | 1 |
| Breithardt, G; Loogen, F; Seipel, L | 1 |
1 review(s) available for quinidine and Ataxia
| Article | Year |
|---|---|
[Long-term treatment of arrhythmias].
Topics: Ajmaline; Arrhythmias, Cardiac; Ataxia; Electric Countershock; Gastrointestinal Diseases; Humans; Lidocaine; Long-Term Care; Phenytoin; Practolol; Procainamide; Propranolol; Psychotherapy; Quinidine; Time Factors | 1974 |
1 other study(ies) available for quinidine and Ataxia
| Article | Year |
|---|---|
Synthesis and toxicopharmacological evaluation of m-hydroxymexiletine, the first metabolite of mexiletine more potent than the parent compound on voltage-gated sodium channels.
Topics: Animals; Anti-Arrhythmia Agents; Aorta; Ataxia; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Caco-2 Cells; Guinea Pigs; Heart; Heart Rate; HEK293 Cells; Humans; Ion Channel Gating; Mexiletine; Mice; NAV1.5 Voltage-Gated Sodium Channel; Permeability; Sodium Channels; Stereoisomerism; Vasodilator Agents | 2012 |